IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,147 | +102.4% | 3,859 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $73,205 | +130623.2% | 3,859 | +7.5% | 0.00% | – |
| Q1 2023 | $56 | -46.2% | 3,589 | -38.5% | 0.00% | -100.0% |
| Q4 2022 | $104 | -99.8% | 5,839 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $59,000 | +210.5% | 5,800 | +20.8% | 0.00% | – |
| Q2 2022 | $19,000 | +850.0% | 4,800 | +1100.0% | 0.00% | – |
| Q1 2022 | $2,000 | -92.9% | 400 | -90.0% | 0.00% | – |
| Q4 2021 | $28,000 | -53.3% | 4,020 | -41.7% | 0.00% | – |
| Q3 2021 | $60,000 | +1400.0% | 6,900 | +1625.0% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -92.4% | 400 | -76.5% | 0.00% | -100.0% |
| Q4 2020 | $79,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |